prof. Isabel Leroux-Roels

Bart Jacobs, Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Nicola Groth, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Azhar Alhatemi (UGent) , Philippe Moris, et al.

(2024) VACCINES. 12(12).

Add to list

Journal Article
A1
open access

Microbiological evaluation of ultraviolet C light-emitting diodes for disinfection of medical instruments

Hannah Siwe (UGent) , Annelies Aerssens (UGent) , Mieke V. Flour, Silke Ternest (UGent) , Leen Van Simaey (UGent) , Duncan Verstraeten, Alain Kalmar (UGent) , Isabel Leroux-Roels (UGent) , Philip Meuleman (UGent) and Piet Cools (UGent)

(2024) HELIYON. 10(17).

Add to list

Journal Article
A1
open access

Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study

Valentino D'Onofrio (UGent) , Sharon Porrez (UGent) , Bart Jacobs (UGent) , Azhar Alhatemi (UGent) , Fien De Boever (UGent) , Gwenn Waerlop (UGent) , Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels (UGent) , et al.

(2024) VACCINES. 12(9).

Academic Bibliography

prof. Isabel Leroux-Roels

Safety and immunogenicity of an adjuvanted clostridioides difficile vaccine candidate in healthy adults : a randomized placebo-controlled phase 1 study

Effectiveness of the XBB.1.5 COVID-19 vaccines against SARS-CoV-2 hospitalisation among adults aged ≥ 65 years during the BA.2.86/JN.1 predominant period, VEBIS Hospital Study, Europe, November 2023 to May 2024

Safety and immunogenicity of a revaccination with a respiratory syncytial virus prefusion F vaccine in older adults : a phase 2b study

Epidemiology and molecular typing of multidrug-resistant bacteria in tertiary hospitals and nursing homes in Flanders, Belgium

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons

One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019

Safety and immunogenicity of a 4-component generalized modules for membrane antigens Shigella vaccine in healthy European adults : randomized, phase 1/2 study

Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults

Microbiological evaluation of ultraviolet C light-emitting diodes for disinfection of medical instruments

Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study

Contents

Support

Contact